Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Hein

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Mutation Research|September 28, 2002
Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesisDavid W Hein
Archives of Toxicology|August 30, 2025
Report on the 2024 international phase II/N-acetyltransferase workshopDavid W Hein
Expert Opinion on Drug Metabolism & Toxicology|April 22, 2009
N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicineDavid W Hein
Pharmacogenetics and Genomics|June 12, 2023
N -acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancerKyung U Hong, David W Hein
Expert Opinion on Drug Metabolism & Toxicology|October 23, 2020
Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused reviewDavid W Hein, Lori M Millner
Pharmacogenomics|June 20, 2017
Role of the N-acetylation polymorphism in solithromycin metabolismDavid W Hein, Mark A Doll
International Journal of Oncology|June 15, 2018
Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell linesSamantha M Carlisle, David W Hein
Analytical Biochemistry|January 30, 2002
Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N-acetyltransferase-1Mark A Doll, David W Hein
The Journal of Pharmacology and Experimental Therapeutics|August 20, 2025
Mini-review: Human N-acetyltransferase genetic polymorphisms in susceptibility to aromatic amine and alkylaniline genotoxicityMariam R Habil, David W Hein
Archives of Toxicology|May 20, 2017
Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotypeDavid W Hein, Mark A Doll
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Mutation Research|September 28, 2002
Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesisDavid W Hein
Archives of Toxicology|August 30, 2025
Report on the 2024 international phase II/N-acetyltransferase workshopDavid W Hein
Expert Opinion on Drug Metabolism & Toxicology|April 22, 2009
N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicineDavid W Hein
Pharmacogenetics and Genomics|June 12, 2023
N -acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancerKyung U Hong, David W Hein
Expert Opinion on Drug Metabolism & Toxicology|October 23, 2020
Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused reviewDavid W Hein, Lori M Millner
Pharmacogenomics|June 20, 2017
Role of the N-acetylation polymorphism in solithromycin metabolismDavid W Hein, Mark A Doll
International Journal of Oncology|June 15, 2018
Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell linesSamantha M Carlisle, David W Hein
Analytical Biochemistry|January 30, 2002
Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N-acetyltransferase-1Mark A Doll, David W Hein
The Journal of Pharmacology and Experimental Therapeutics|August 20, 2025
Mini-review: Human N-acetyltransferase genetic polymorphisms in susceptibility to aromatic amine and alkylaniline genotoxicityMariam R Habil, David W Hein
Archives of Toxicology|May 20, 2017
Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotypeDavid W Hein, Mark A Doll
Pageof 18